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Neonatal mice deﬁcient in IjB-a, an inhibitor of the ubiquitous transcription factor NF-jB, develop severe and
widespread dermatitis shortly after birth. In humans, inﬂammatory skin disorders such as psoriasis are associated
with accumulation in the skin of the unusual arachidonic acid metabolite 12R-hydroxyeicosatetraenoic acid (12R-
HETE), a product of the enzyme 12R-lipoxygenase. To examine the etiology of the murine IjB-a-deﬁcient skin
phenotype, we investigated the expression of lipoxygenases and the metabolism of exogenous arachidonic acid in
the skin. In the IjB-a-deﬁcient animals, the major lipoxygenase metabolite was 8S-HETE, formed together with a
minor amount of 12S-HETE; 12R-HETE synthesis was undetectable. Skin from the wild-type littermates formed 12S-
HETE as the almost exclusive lipoxygenase metabolite. Upregulation of 8S-lipoxygenase (8-LOX) in IjB-a-deﬁcient
mice was conﬁrmed at the transcriptional and translational level using ribonuclease protection assay and western
analysis. In immunohistochemical studies, increased expression of 8-LOX was detected in the stratum granulosum
of the epidermis. In the stratum granulosum, 8-LOX may be involved in the terminal differentiation of keratinocytes.
Although mouse 8S-lipoxygenase and human 12R-lipoxygenase are not ortholog genes, we speculate that in
mouse and humans the two different enzymes may fulﬁll equivalent functions in the progression of inﬂammatory
dermatoses.
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Nuclear factor kB (NF-kB) is a ubiquitous transcription
factor involved in inflammatory and immune responses. In
resting cells, NF-kB is retained in the cytosol by forming a
complex with one of several members of the protein family
inhibitor of kB (IkB). Among the seven vertebrate IkB
proteins, IkB-a is recognized as the functionally most
important inhibitor of NF-kB. Stimulation of resting cells
through appropriate signals leads to phosphorylation and
degradation of IkB, and subsequent translocation of
the liberated NF-kB to the nucleus (Baldwin, 1996; Sha,
1998).
In mice deficient of IkB-a, NF-kB is constitutively active
(Beg et al, 1995; Klement et al, 1996; Chen et al, 2000b). In
the first 4–5 d after birth, the skins of IkB-a/ and wild-
type mice are phenotypically indistinguishable. On days 6–
7, a dermatitis phenotype appears, and the skin becomes
dry, scaly, flaky, and the development of hair is impaired.
IkB-a/ pups typically die within 9 d after birth. Neonatal
lethality of the knockouts was overcome by use of the RAG2
(recombination activating gene 2) blastocyst complementa-
tion system to generate chimeric animals (Chen et al,
2000b). All mature lymphocytes of the chimeras are derived
from the IkB-a/ embryonic stem cells, and the contribu-
tion of the RAG2-deficient blastocysts is able to rescue the
neonatal lethality. The RAG2/, IkB-a/ chimeras are
normal at birth, and the dermatitis develops at about 5 wk
after birth. Histologically, the disease phenotype of the
chimeras is characterized by hyperplastic epidermal kera-
tinocytes, dermal infiltration of immunocompetent cells
including lymphocytes, and formation of microabscesses.
Since epidermal hyperplasia and lymphocyte infiltration are
two main characteristics of psoriasis in humans, the overall
phenotypic and histologic characterization of chimeric IkB-
a-deficient mice suggested that these animals could serve
as a highly suitable model to study molecular events of
human psoriasis or severe widespread dermatitis (Chen
et al, 2000b).
In humans, the metabolism of arachidonic acid in
psoriasis and other proliferative dermatoses is character-
ized by the accumulation of the unusual metabolite 12R-
hydroxyeicosatetraenoic acid (12R-HETE) (Hammarstro¨m
et al, 1975; Baer et al, 1991). Formation of 12R-HETE results
from the activity of 12R-lipoxygenase (LOX) in the psoriatic
lesions (Boeglin et al, 1998); in normal human skin, 12R-LOX
activity is almost undetectable. Mutations in the coding
region of the 12R-LOX gene (ALOX12B) were identified
recently in patients with non-bullous congenital ichthyosi-
form erythroderma (NCIE), a familial skin disease with a
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disorder of impaired keratinization (Jobard et al, 2002).
Prompted by the knowledge that alterations in the lipox-
ygenase metabolism of arachidonic acid are involved
in several human hyperproliferative epidermal disorders
including psoriasis, we investigated lipoxygenase expres-
sion and activity in the affected skin of IkB-a knockout
mice.
12R-LOX was a likely candidate as an altered lipox-
ygenase in the affected skin of IkB-a-deficient mice due to
available information with respect to human psoriasiform
disease and NCIE. We did not limit our investigation to this
isoform however, as a multitude of lipoxygenases are
expressed in mouse skin, and there is high homology within
the family of lipoxygenases across species (Fig 1). Here we
report the characterization of the lipoxygenase activity in
this cutaneous model using animals deficient in IkB-a.
Results
Arachidonic acid metabolism in the skin of wild-type
and IjB-a-deﬁcient mice The metabolism of exogenous
radiolabeled arachidonic acid was analyzed in epidermal
homogenates of IkB-a-deficient mice and control litter-
mates. In the IkB-a/ animals, the entire dorsal epidermis
was affected by the dermatitis phenotype, and the affected
skin was used for the experiments. The control mice
showed higher conversion of substrate to lipoxygenase-
derived products than the IkB-a-null mice (12%, 25%, and
27% in controls compared to 3%, 6%, and 10% in the IkB-
a-deficient littermates). Product analysis showed that this
was associated with a dramatic switch in enzymatic
activities.
Initial analysis of radiolabeled arachidonic acid metabo-
lites using reversed-phase HPLC (RP-HPLC) showed the
formation of lipoxygenase-derived HETEs as the most
prominent radiolabeled products, together with less
amounts of early eluting polar products that corresponded
in retention time to prostaglandins (Fig 2, A and B). The
individual HETE isomers were not resolved under these RP-
HPLC conditions, and therefore the HETE products were
collected as a pooled fraction from RP-HPLC and analyzed
further using SP-HPLC. In the epidermis of control mice,
12-HETE was the almost exclusive component in the HETE
fraction (Fig 2C), and chiral analysis revealed the config-
uration as 498% 12S-HETE (Fig 2E). This is the product
expected of any of the three 12S-LOX enzymes expressed
Figure 1
Phylogenetic relationship of human and mouse lipoxygenases. The
subgroup of epithelial lipoxygenases is shown in a gray box. The
homolog of mouse 8-LOX is the second type of 15S-LOX in humans
(15-LOX-2) (Brash et al, 1997; Jisaka et al, 1997). The phylogenetic tree
was constructed using the MegAlign program of the DNAstar software
package (Lasergene, Madison, WI).
Figure2
HPLC analysis of the metabolism of [1-14C]arachidonic acid in skin
homogenates of wild-type and IjB-a-deficient mice. The panels on
the left show results from wild-type, and the panels on the right show
results from IkB-a/ mice. (A) and (B) show chromatograms from the
initial RP-HPLC analysis where the individual HETE isomers co-elute. In
(C) and (D), the collected HETE fractions from RP-HPLC have been re-
chromatographed as the methyl esters using SP-HPLC. In (C) the
retention times of HETE isomers are indicated by arrows. (E–G) Chiral
phase HPLC analysis of 12-HETE (wild-type, panel E), 12-HETE (IkB-
a/, panel F), and 8-HETE (IkB-a/, panel G) collected from SP-
HPLC. Incubations with [1-14C]arachidonic acid, extraction, and HPLC
conditions are described in Materials and Methods. The chromato-
grams shown are representative of several independent experiments.
692 SCHNEIDER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
in mouse skin (Heidt et al, 2000; Siebert et al, 2001). In the
IkB-a/ mice, 8-HETE was the major metabolite together
with about 20%–25% in abundance of 12-HETE (Fig 2D).
Stereochemical analysis of the minor 12-HETE product in
the IkB-a/ skin homogenates revealed, as in the
controls, a purely 12S-configuration (Fig 2F). The 12S
chirality ruled out the participation of the 12R-LOX enzyme
in the biosynthesis of 12-HETE. Stereochemical analysis of
the 8-HETE formed in the IkB-a/ skin homogenates
showed that it was exclusively of the S-configuration (Fig
2G), as expected for its biosynthesis by the mouse skin 8S-
LOX (Jisaka et al, 1997; Krieg et al, 1998). Formation of
other HETE isomers such as 5-HETE or 15-HETE was not
observed in the control or in the IkB-a/ mice.
Based on previous reports on increased 12R-HETE
formation in human psoriasis and in other abnormalities of
epidermal differentiation, we carefully analyzed for the
expression of 12R-LOX activity in the IkB-a/ and wild-
type mice. The recombinant mouse 12R-LOX does not
oxygenate free arachidonic acid, and to date only the
methyl ester of arachidonic acid has been reported to be a
substrate (Krieg et al, 1999). Therefore, skin homogenates
were incubated with [1-14C]arachidonic acid methyl ester
and analyzed using HPLC conditions as described above.
The formation of 12R-HETE methyl ester was not detected
in these analyses. Northern and RPA assays, as well as
western blot analyses using a polyclonal antibody raised
against recombinant human 12R-LOX failed to detect
expression of 12R-LOX in skin homogenates of either IkB-
a-deficient or control animals (not shown).
Analysis for 12-lipoxygenase isozymes Due to limita-
tions of sensitivity, we were unable to identify the enzyme(s)
responsible for the 12S-HETE synthesis in the wild-type and
IB-a-deficient animals. The most likely candidate is the
platelet-type 12S-LOX, an enzyme with an activity profile
what most closely matches what we observe. The platelet-
type 12S-LOX forms purely 12S-HETE from arachidonic
acid whereas both the leukocyte-type and epidermal-type
12S-LOX enzymes form 15S-HETE as a significant second
metabolite (Chen et al, 1994; McDonnell et al, 2001). 15-
HETE was not evident on our HPLC chromatograms (Fig 2).
Although the epidermal-type 12-LOX has been cloned from
mouse skin, it is actually the least likely candidate because
the recombinant protein is known to possess exceptionally
low catalytic activity (Funk et al, 1996; Burger et al, 2000).
Using specific commercial antibodies, we could not detect
expression of platelet-type 12S-LOX. We used three
different antibodies raised against the leukocyte-type 12S-
LOX or its human homolog and could not detect expression
of this LOX. Given that we were unable to identify 12-LOX in
the skin samples, we are limited in what we can say about
the downregulation of the enzyme in the knockout animals.
Although it is not clear why constitutive activation of NF-kB
is associated with the reduced 12-LOX activity that we
observe in the IkB-a-deficient mouse skin, a role for 12-
lipoxygenases is implied in normal skin differentiation (e.g.
for the platelet-type 12S-LOX in the normal barrier
functioning (Johnson et al, 1999)), and the appropriate
stage for its expression may be bypassed in this dermatitis
model.
Western and ribonuclease protection analyses Tran-
scriptional regulation of 8-LOX was analyzed using RNA
isolated from the skins of chimeric RAG2/, IkB-a/
mice (Chen et al, 2000a, 2000b). The chimeras were used to
generate adult mice and thus circumvent the fact that the
IkB-a/ animals die around neonatal day 9. The chimeric
mice were generated using the RAG2 (recombination
activating gene 2) blastocyst complementation system.
Using this technique, IkB-a/ lymphocytes were trans-
ferred into RAG2/ recipient mice, and the resulting
chimeras live into adulthood. Two of three chimeric mice
generated using this method developed a psoriasiform skin
disease (Chen et al, 2000b). Expression analysis by RNase
protection assay using RNA from the two affected animals
and of two control littermates proved upregulation of 8-LOX
mRNA in the diseased animals (Fig 3A). Subsequent
western blot analyses confirmed the induction of 8-LOX
protein in skin homogenates of IkB-a/ mice as com-
pared to wild-type animals (Fig 3B).
Figure3
Induction of 8-LOX expression in the dorsal skin of IjB-a/mice.
In (A) total RNA isolated from RAG2/, IkB-a/ mice was used.
RNase protection assay indicates upregulation of 8-LOX mRNA in the
skins from diseased animals (/) as compared with those from control
animals (þ /þ ). The different levels of 8-LOX mRNA in the two chimeric
animals are most likely due to differences in the relative contribution of
RAG2/, IkB-aþ /þ versus RAG2þ /þ , IkB-a/ cells in the skin of
the two animals. The two lanes on the right show normal mouse skin
treated with the vehicle acetone (ac.) or with TPA to induce 8-LOX
expression. RNA was isolated using TRI reagent, and 5 mg each was
used in the assay using a probe specific for mouse 8-LOX (  400 bp).
L32 and GAPDH (both  150 bp) were used as loading controls. (B)
Western blot detection of 8-LOX expression in the dorsal skin of wild-
type (lanes 2–4) and IkB-a/ mice (lanes 5–7) using a polyclonal
antibody raised against human 15-LOX-2. For the skin samples, 30 mg
of protein was loaded onto a 10% SDS-PAGE gel and blotted on a
0.2 mm nitrocellulose membrane. In lane 1, a standard of mouse 8-LOX
expressed in HEK 293 cells was loaded. A mouse monoclonal antibody
raised against a-tubulin was used as loading control.
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Immunohistochemical analyses The results of the ara-
chidonic acid incubations and RPA and western analyses
indicated increased expression and activity of 8-LOX in the
knockout animals. In order to localize this aberrant expres-
sion, immunohistochemical analysis was performed on
dorsal skin sections.
The antibody used for immunohistochemistry has been
shown to detect 8-LOX expression in mouse epidermis
(Jisaka et al, 1997; Muga et al, 2000). Sections of dorsal
skins from 6-to7-d-old wild-type and IkB-a-deficient mice
were fixed in 10% formaldehyde, embedded, sectioned,
stained with standard hematoxylin and eosin, and immu-
nostained to determine the distribution of 8-LOX (Fig 4).
Additional immunostaining with markers for immune cells (T
lymphocytes and macrophages) and for the various
epidermal compartments was performed (Fig 4). Gram
Figure 4
Immunohistochemical analysis of 8-LOX
expression and of morphological differ-
ences between the dorsal skins of IjB-a-
deficient (left panels) and wild-type mice
(right panels). (A) The epidermis is greatly
thickened in the outer epidermis of the IkB-a/
 mice; a small microabscess is visible
(indicated by arrows). (B) The epidermis is
unremarkable in the wild-type mice. (A, B)
Hematoxylin and eosin staining. (C) Positive
immunoreactivity for 8-LOX expression was
detected in the stratum granulosum of IkB-a-
deficient mice. (D) Immunoreactivity for 8-LOX
was not detected in the epidermis of wild-type
mice. (E) The distribution of keratin-1 in IkB-
a/ mice indicates an expanded suprabasal
compartment leading to a thickening in the
stratum corneum. (F) Keratin-1 immunoreactiv-
ity in the suprabasal epidermal compartment in
wild-type mice shows the normal suprabasal
distribution. (G) The majority of cells along the
basal layer are stained with the proliferative
marker Ki67 in the IkB-a/ mice. (H) Only a
few proliferative cells are present in the
epidermis of this wild-type mouse. (I) The
involucrin marker shows immunoreactivity in
the expanded differentiated compartment of
the outer epidermis of an IkB-a-deficient
mouse. (J) The involucrin marker shows mini-
mal thickness in the wild-type mouse. Size bar,
50 mm.
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staining and periodic acid staining were unremarkable,
indicating that the cause for the disease was genetic and
not due to infection.
The knockout mice in this study showed a rapid onset of
dermatitis that required their euthanization at 8–9 d of age.
Several hallmarks of epidermal hyperproliferation and
severe dermatitis are obvious in the skin samples. Figure
4A illustrates a small microabscess in the outer epidermis.
This was a prominent feature, and many of the abscesses
were considerably larger. The number of epidermal layers
was greatly increased in the knockout mice as compared to
the wild-type. In addition to the morphologically obvious
thickening, quantitative morphometric measurements were
performed. The average epidermal thickness in the IkB-a-
deficient mice was 50.5  5.1 mm and in the wild-type was
16.7  4.8 mm (Fig 4A and B). In the IkB-a-deficient mice, a
prominent signal for 8-LOX expression was localized to the
stratum granulosum (Fig 4C). Staining for 8-LOX was absent
in the epidermis of wild-type mice as expected from the
results of the activity and expression analyses (Fig 4D).
Keratin-1 was used as a marker for the suprabasal region of
the epidermis. Staining with an antibody against keratin-1
revealed an apparent expansion of the number of layers of
keratinocytes within the differentiated region of the epider-
mis in the IkB-a-deficient mice as compared to the control
mice (Fig 4E and F). An overall higher cell density was
observed in the dermis of the IkB-a-deficient mice as
compared to the wild-type littermates.
Since a thickened epidermis can be the result of an
increase in cell proliferation and/or an increase in the outer,
more differentiated compartment, we conducted additional
immunohistochemical assays with specific markers. The
extent of the proliferative compartment was revealed with
Ki67 immunostaining (Fig 4G and H). The number of
proliferating cells was greatly increased along the basal
layer in the IkB-a-deficient mice as compared to the wild-
type. It is noteworthy that the labeled nuclei are largely
restricted to the basal layer and are not expanded above the
most basal layer as one would expect to see in psoriatic
disease. The numbers of proliferating cells are greatly
increased in the keratinocytes associated with hair follicles.
This was an expected finding since this is the time of active
growth of the first coat of fur. Additional staining with an
immunomarker that is restricted to the outer, most highly
differentiated skin layers (involucrin) confirmed that the most
differentiated epidermal compartment was expanded in IkB-
a-deficient mice (Fig 4I and J). Although neutrophilic
infiltrates were readily observed in the hematoxylin- and
eosin-stained sections and were a prominent feature in the
outer epidermis and sloughing flaky layers, CD4þ cells were
not increased in the IkB-a-deficient mice (data not shown).
The numbers of macrophages as highlighted by the macro-
phage marker F4/80 were likewise not significantly changed
between the IkB-a-deficient and the wild-type animals.
Discussion
Psoriasis is a chronic hyperproliferative and hyperinflam-
matory skin disease characterized by hyperplasia and
impaired differentiation of epidermal keratinocytes. The
inflammatory reaction is caused by infiltration into the
epidermis of immunocytes, e.g., T lymphocytes and
macrophages. In humans, psoriatic lesions have abnormal
arachidonic acid metabolism, leading to the accumulation
of the unusual product 12R-HETE as the major metabolite
(Hammarstro¨m et al, 1975; Baer et al, 1991). The formation
of 12R-HETE in psoriasis is the result of the activity of 12R-
LOX, which has very low levels of activity in normal human
skin (Boeglin et al, 1998). The physiological consequences
of 12R-HETE synthesis by 12R-LOX are not understood,
and our original hypothesis was that the IkB-a-deficient
mice would represent an appropriate model to investigate
these consequences. Analysis of the LOX metabolism of
arachidonic acid in the skins of IkB-a-deficient mice
revealed the unexpected result of prominent formation of
8S-HETE in the IkB-a/ animals. The wild-type animals,
by contrast, formed mainly 12S-HETE. Formation of 12R-
HETE was not observed in the IkB-a/ or the wild-type
animals. We can conclude that either this mouse model of
psoriasis differs from the human condition with respect to
the role of its arachidonic acid metabolites or, another
tenable possibility, that the functions of human 12R-LOX in
psoriasis and related dermatoses are taken over by the
8-LOX enzyme in the mouse.
Seven functional LOX genes are expressed in the mouse,
all of which can be detected in mouse skin. These are the
platelet, leukocyte, and epidermal types of 12S-LOX, 5-
LOX, 8-LOX, 12R-LOX, and eLOX3 (Fig 1) (Brash, 1999;
Heidt et al, 2000). The latter three enzymes form a subgroup
of epithelial-specific lipoxygenases located on a gene
cluster on mouse chromosome 11, and the proteins share
about 50% amino acid identity (Heidt et al, 2000). In the
epidermis of most mouse strains, 8-LOX protein and activity
are almost undetectable or absent (Fu¨rstenberger et al,
1991; Hughes and Brash, 1991). Expression of the enzyme
is highly inducible upon topical application of the tumor
promoter 12-O-tetradecanoylphorbol-13-acetate (TPA),
although the extent of this induction is strain dependent
(Gschwendt et al, 1986; Hughes and Brash, 1991). TPA
treatment of the skin leads to a phenotype of inflammation
with epidermal hyperplasia within 24 h of treatment. Mouse
12R-LOX has a peculiar substrate specificity, and so far
arachidonic acid methyl ester is the only substrate reported
to be oxygenated by the recombinant enzyme in vitro (Krieg
et al, 1999). A naturally occurring substrate for mouse 12R-
LOX has yet to be identified. Likewise, 12R-HETE has not
been detected as an endogenous arachidonic acid meta-
bolite in mouse skin. Based on the temporal expression
pattern of 12R-LOX in the skin during mouse embryonic
development, it was suggested that the enzyme might have
a functional role in development of the epidermis (Sun et al,
1998). The identification and cloning of mouse eLOX3 was
reported several years ago, however, for the recombinant
and expressed enzyme, no oxygenation of arachidonic acid
or any other polyunsaturated fatty acid substrate has yet
been described (Kinzig et al, 1999). Recent studies
identified a catalytic activity for human eLOX3 in the
conversion of HPETE substrates to specific epoxyalcohol
products (Yu et al, 2003).
Upon immunohistochemical analyses, we detected ex-
pression of 8-LOX in the stratum granulosum of the affected
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epidermis of the knockouts while there was no staining in
the wild-type animals. In the stratum granulosum, 8-LOX
co-localized with keratin-1, indicating that this LOX is
expressed in differentiating keratinocytes. This was further
confirmed using staining for involucrin as an additional
marker of epidermal differentiation (Fig 4). A similar
localization also occurred in transgenic mice overexpres-
sing 8-LOX under the influence of a loricrin promoter; 8-LOX
was expressed in the suprabasal epidermis and the
phenotype was characterized by epidermal thinning and a
high degree of differentiation and keratinization (Muga et al,
2000). In the same study, it was found that the 8-LOX
metabolite 8S-HETE could act as a ligand for the nuclear
receptor PPARa, and thus mediate calcium-induced kera-
tinocyte differentiation through a pathway involving PPARa
(Muga et al, 2000; Thuillier et al, 2002). 8S-HETE is generally
recognized as a potent PPARa ligand (Yu et al, 1995),
although 8R-HETE and 12R-HETE were equipotent with 8S-
HETE in inducing mouse keratinocyte differentiation in a
low-calcium medium (Thuillier et al, 2002). Given these
considerations, it seems plausible that 8-LOX expression in
IkB-a/mice is part of a program initiated in an attempt to
terminally differentiate the large number of proliferating
keratinocytes.
The thickened outer compartment in the skins of the IkB-
a/ mice may be the end-stage response to excessive
proliferation in the underlying basal epidermis. Immunos-
taining with a proliferative marker provided an indirect
indicator that signals in the basal compartment of the
epidermis are likewise affected by the deficiency in IkB-a.
Although the numbers of proliferating cells were greatly
increased in the IkB-a-deficient mice, surprisingly the
labeled nuclei remained restricted to the basal compart-
ment. This observation does not resemble abnormalities in
psoriasiform lesions where the proliferative cell layer is
typically expanded to several layers deep. Thus at least in
this early stage of development (6–7 d after birth), the
phenotypic signs in these mice have not had sufficient time
to develop into a full-blown psoriasiform skin disease. An
alternative possibility is that the phenotype developed by
the IkB-a-deficient animals is a unique type of dermatosis
that is not akin to psoriasis. The role of 8-LOX in both
phenotypes, however, may be identical based on the fact
that expression was detected in the chimeras and in the
IkB-a/ animals.
The idea that the mouse 8-LOX might assume a function
in promoting keratinocyte differentiation is compatible with
current concepts of the role of its human homolog. The
phylogenetic counterpart of the mouse 8-LOX in humans is
the second type of mammalian 15-lipoxygenase, 15-LOX-2
(Fig 1). In humans, this lipoxygenase is mainly expressed in
secretory epithelial tissue, e.g., sebaceous glands of hair
follicles, and the secretory epithelium in the prostate
(Shappell et al, 2001b). In the prostate, 15-LOX-2 appears
to modulate the differentiation of prostate epithelial cells
(Shappell et al, 2001a). Its expression is lost in prostate
neoplasia and adenocarcinoma (Shappell et al, 1999), and it
acts as a negative regulator of the cell cycle in normal
prostate epithelial cells (Tang et al, 2002). Overall, the
physiological function of 15-LOX-2 is related to a differ-
entiation phenotype, and it has been shown that 15-LOX-2-
derived arachidonic acid metabolites can serve as ligands
for nuclear receptors of the PPAR family (Shappell et al,
2001a).
Multiple studies have shown that elevated NF-kB activity
can alter cellular proliferation (Seitz et al, 1998; Bell et al,
2003; Hinata et al, 2003). In this model, the hyperactivation
of NF-kB caused by the absence of the major inhibitor IkB-a
results in hyperplasia of epidermal keratinocytes and a
psoriasis-like skin disease. Our data show that under these
circumstances the level of 8-LOX expression increases in
the stratum granulosum of the epidermis. This may be
suggestive that elevated 8-LOX is not a causal component
of the pathophysiology of the disease, but may be induced
in an attempt to differentiate the excess cell population.
This conclusion has important implications for the potential
role and significance of arachidonic acid-metabolizing
enzymes in therapeutics. Further insights into the participa-
tion of 8-LOX in the progression of cutaneous disease in
IkB-a/ mice could be derived from the use of genetically
altered animals, 8-LOX knockouts, and 8-LOX overexpres-
sing transgenic mice. Conceptually, a potential role of the
8-LOX as an inducing factor in keratinocyte differentiation is
in clear distinction to a role in promoting the phenotype of
psoriasis in the chimeric IkB-a/ animals. To induce
differentiation is to counteract the lack of differentiation,
which is one of the hallmarks of psoriasis. Thus, a prospect
for future studies is to examine the effects of manipulating
8-LOX expression. A central issue still to be resolved is
whether the same function within the pathophysiology
of psoriasis is fulfilled by phylogenetically different en-
zymes, 12R-LOX in human psoriasis and 8-LOX in the
mouse model. The results of this study suggest such a
possibility.
Materials and Methods
Generation of IjB-a-deﬁcient mice The IkB-a knockout animals
were generated as described before (Chen et al, 2000a). The
animal studies have been approved by the local IRB.
Analysis of [1-14C]arachidonic acid metabolites in skin homo-
genates Neonatal mice were selected as wild-type/heterozygote
or / based on the appearance of the skin, and the genotype
was confirmed by Southern analysis. As previously reported, the
epidermal thickening and red, flaky phenotype develops only in
homozygote null animals (Klement et al, 1996; Chen et al, 2000b;
Huber et al, 2002). Six- to seven-day-old wild-type and IkB-a/
mice were anesthetized using carbon dioxide and euthanized by
decapitation. A section of dorsal skin was collected and placed on
a piece of filter paper on a block of dry ice. The epidermis of the
frozen skin was scraped off with a scalpel as described (Hughes
and Brash, 1991) and transferred to a tube containing 300 mL
50 mM Tris-HCl and 150 mM NaCl (pH 7.5). After brief sonication
(5–10 s), the samples were centrifuged briefly at 1500  g in a
benchtop centrifuge. To 100 mL of the supernatant, 100 mM
[1-14C]arachidonic acid (NEN Life Science Products, Boston,
Massachussets) was added in 1 mL ethanol, and the samples
were incubated with shaking at 371C for 45 min. Products were
extracted using the procedure of Bligh and Dyer (1959) including
1 mg triphenylphosphine to ensure that any arachidonate hydro-
peroxides were reduced to HETE. After the addition of 250 ng each
of unlabeled racemic HETE as internal standards for HPLC analysis
(to establish the precise retention times using an online UV
detector), the formation of radiolabeled products was analyzed
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by injecting a 20% aliquot of the samples on a Waters Symmetry
(Waters, Milford, MA) C18 column (5 mm particle size, 25  0.46
cm) eluted with methanol/water/acetic acid (90/10/0.01, by
volume) at a flow rate of 1 mL per min. The column effluent was
monitored using an HP 1040A diode array detector coupled to a
Packard Radiomatic Flo-one radioactive flow detector (Packard,
Downers Grove, IL). The RP-HPLC solvent system only partly
resolves 8- and 12-HETE. Therefore, the rest of the sample was run
on RP-HPLC, and the HETE region of the chromatogram was
collected and further analyzed by SP-HPLC using a Beckman
Ultrasphere Silica 5-mm column (25  0.46 cm) eluted with hexane/
isopropyl alcohol/acetic acid (100/2/0.1, by volume) (Beckman,
Fullerton, CA).
For chiral analysis of 8-HETE and 12-HETE, the products were
methylated using ethereal diazomethane and re-purified by SP-
HPLC using a Beckman Ultrasphere Si 5-mm column (25  0.46
cm) eluted with hexane/isopropyl alcohol/acetic acid (100/1/0.1, by
volume) at a flow rate of 1 mL per min. Chiral separation was
performed on a Chiralpak AD column (Chiral Technologies, Exton,
Pennsylvania) (25  0.46 cm) using a solvent of hexane/methanol
(100/2, by volume) at a flow rate of 1 mL per min (Schneider et al,
2000). Elution from chiral phase HPLC was monitored using a
Hewlett-Packard 1040A diode array detector coupled to the
radioactive flow detector.
Ribonuclease protection assay RNA expression levels were
analyzed in the skins of control and chimeric RAG2/, IkB-a/
 mice. These mice display a thickened epidermal phenotype
when compared to the IkB-a/ mice, but live into adulthood
(Chen et al, 2000b). For RNA preparation, the complete back skins
of RAG2/, IkB-a/ chimeras and control mice were removed
and homogenized in 2 mL of Tri Reagent (Molecular Research
Center, Cincinnati, OH) using a polytron homogenizer. RNA
extraction was completed following the manufacturer’s instruc-
tions. 8-LOX mRNA levels in the skin were analyzed using the
RiboQuant Multi-Probe RNAse Protection Assay System according
to the manufacturer’s instructions (PharMingen, San Diego,
California). Five micrograms of total skin RNA was analyzed per
reaction using 32P-labeled anti-sense RNA templates specific for
8-LOX and the internal loading controls L32 and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). RNA templates specific for
L32 and GAPDH were transcribed using an mCK-3b Custom
Template Set (PharMingen) according to the manufacturer’s
instructions. An RNA template specific for 8-LOX was transcribed
in a separate reaction using a cDNA template and T7 RNA
polymerase to produce undigested and protected RNA templates
of 478 and 402 nucleotides, respectively. To produce the 8-LOX
DNA template, the HindIII/XhoI fragment of 8-LOX in pCR 2.1 (Jisaka
et al, 1997) was subcloned into the corresponding sites of pBS
SK() (Stratagene, La Jolla, California) and linearized with NcoI.
Western analysis The protein extracts were quantified using the
Bradford assay (Bio-Rad, Hercules, CA), and aliquots of 30 mg of
protein of the skin homogenates were separated by SDS-
polyacrylamide gel electrophoresis and then transferred electro-
phoretically to a 0.2 mm nitrocellulose membrane (Bio-Rad). The
membranes were probed using rabbit polyclonal antibodies
specific for mouse 8-LOX (Jisaka et al, 1997) and human/mouse
12R-LOX. The 12R-LOX antibody is suitable to detect about 10 ng
of recombinant 12R-LOX in western analyses (1:500 dilution). The
following antibodies were used for the detection of additional LOX
isozymes: human 5-LOX (rabbit polyclonal, Cayman Chemical, Ann
Arbor, MI), human platelet 12S-LOX (rabbit polyclonal, Oxford
Biomedical, Oxford, MI), mouse leukocyte 12S-LOX (rabbit
polyclonal, Cayman Chemical), human 15-LOX-1 (sheep polyclonal
from Dr Joseph Cornicelli and rabbit polyclonal from Dr Douglas
Conrad). Recombinant human 5-LOX, human 15-LOX-1, and
human platelet lysate were loaded as positive controls. For loading
controls, a mouse monoclonal antibody raised against a-tubulin
was used in a 1:1000 dilution (Santa Cruz, CA). Donkey anti-rabbit
IgG or sheep anti-mouse IgG linked with horseradish peroxidase
(Amersham Life Science, Piscataway, NJ) was used as the
secondary antibody. Specifically bound protein was detected
using the ECL method and detection of chemiluminescence by
exposure to Hyperfilm (Amersham Life Science).
Immunohistochemical analysis Dorsal skins were harvested and
fixed in 10% formaldehyde solution and processed for paraffin
embedding. Tissues were sectioned, stained with hematoxylin and
eosin, indicators of possible pathogenic organisms (gram staining,
periodic acid Schiff stain), and a series of immunostaining assays
was performed using standard markers to determine the status of
epidermal proliferation and differentiation. Immunostaining for
8-LOX was carried out as described previously (Jisaka et al,
1997). The proliferating population of cells was demonstrated with
immunostaining for Ki67. This was performed at a dilution of
1:1500 (Novacastra Labs, Newcastle, UK). The suprabasal
compartment of the epidermis was selectively highlighted using
keratin-1 immunostaining with a polyclonal antibody in a 1:500
dilution (Covance, Richmond, California). The most differentiated
epidermal compartment was highlighted with involucrin immunos-
taining at a dilution of 1:500 (Covance). Tissues were further
reacted with an immunomarker for T-lymphocytes (CD4) at a
dilution of 1:50 (Santa Cruz) and an immunomarker for macro-
phages (F4/80) at a dilution of 1:100 (Serotec). All reactions were
completed with an Envisionþ kit from Daco (Carpintera, Califor-
nia), and the DAB chromagen was used. Epidermal thickness was
measured in a blinded fashion from three knockout and two wild-
type animals using 20 random data points along the dorsal surface
of each animal.
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